"The Queen Elizabeth II Jubilee Hospital is a medium metropolitan adult facility providing a range of inpatient and outpatient services and a 24-hour emergency department. Our endoscopy unit is Australia’s most advanced diagnostic facility and has the capacity to see more than 5000 patients a year."

During the past decade, Queen Elizabeth II Jubilee Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Jubilee Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Global Coalition for Adaptive Research" with 1 trials as a collaborator, "Intensive Care National Audit & Research Centre" with 1 trials as a collaborator and "Medical Research Institute of New Zealand" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Jubilee Hospital" are "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Jubilee Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth II Jubilee Hospital" are "Biological" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials), "Angiotensin Receptor Blockers" (1 trials) and "Angiotensin converting enzyme inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth II Jubilee Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Queen Elizabeth II Jubilee Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Queen Elizabeth II Jubilee Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth II Jubilee Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".